Huiying Zhang

Dr. Huiying Zhang


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

22 April 2024 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
YFYaru Feng
Yaru Feng
MLMengying Li
Mengying Li
XLXue Li
Xue Li
QTQingtao Tang
Qingtao Tang
XLXiaoyan Li
Xiaoyan Li
HZHuiying Zhang
Huiying Zhang

1 July 2021 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
YZYanfang Zhang
Yanfang Zhang
DLDan Li
Dan Li
QYQi Yan
Qi Yan
XSXueru Song
Xueru Song
WTWenyan Tian
Wenyan Tian
FXFeng-Xia Xue
Feng-Xia Xue
Purpose: To evaluate the effects of body weight loss on reproductive outcomes in young women with early-stage endometrial cancer (EC) and atypical hyperplasia (AH) who underwent fertility-sparing therapy. Patients and Methods: Patients with well-differentiated EC (n=8, FIGO stage Ia) and AH (n=36) who achieved complete regression after fertility-sparing therapy were retrospectively reviewed. Patients were divided into a weight loss group (n=25) and a non-weight loss group (n=19). Subgroup analysis according to body mass index and relative weight loss were performed to investigate the effect of weight loss on pregnancy and live birth outcomes. Univariate and multivariate logistic regression analyses were undertaken to determine pregnancy-associated factors. Results: Mean body weight and body mass index at pre-progestin treatment and at fertility treatment initiation were 70.63± 12.03 and 67.08± 8.18 kg, respectively, 27.06± 4.44 and 25.73± 3.15 kg/m2, respectively. Twenty-five patients (56.82%) lost weight, the median absolute weight loss was 5.00 kg (1.00– 34.50), and the median relative weight loss was 6.70% (1.00– 36.00%) over a median of 12 months (5.00– 97.00). A favorable pregnancy rate (65.91%) and live birth rate (50.00%) were achieved. The pregnancy and live birth rates were meaningfully higher in the weight loss group than in the non-weight loss group (88.00% vs 36.84%, P=0.000; 64.00% vs 31.58%, P=0.033); weight loss ≥ 5% significantly increased pregnancy and live birth rate in patients with BMI ≥ 25 kg/m2. The risk ratio of weight loss ≥ 5% in multivariate logistic analysis for pregnancy was 10.448 (1.102, 99.056, P=0.041). Conclusion: Weight loss could positively affect pregnancy rate and improve live birth rate in overweight and obese women with early-stage EC and AH during/after fertility-sparing therapy. Weight loss ≥ 5% increased pregnancy and livebirth rates significantly in overweight and obese women.

27 September 2022 in Journal of Solid State Chemistry
Verified
Journal Article
Closed access
HYHong-Kun Yang
Hong-Kun Yang
YYYang Yu
Yang Yu
ZZZi-Hao Zhao
Zi-Hao Zhao
HZHuiying Zhang
Huiying Zhang
YZYi-Ming Zhang
Yi-Ming Zhang
YHYuan Chun He
Yuan Chun He

27 March 2024 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
DKDan Kuai
Dan Kuai
QTQingtao Tang
Qingtao Tang
XWXiang Wang
Xiang Wang
QYQi Yan
Qi Yan
WTWenyan Tian
Wenyan Tian
HZHuiying Zhang
Huiying Zhang

3 July 2023 in Discover Oncology
Verified
Journal Article
Open access
PDF file
DKDan Kuai
Dan Kuai
QTQingtao Tang
Qingtao Tang
WTWenyan Tian
Wenyan Tian
HZHuiying Zhang
Huiying Zhang
Purpose: We investigated endometrial hyperplasia (EH) and endometrial endometrioid cancer (EEC) and developed a nomogram model to predict the EH/EEC risk and improve patients’ clinical prognosis. Methods: Data were collected from young females (age: ≤ 40 years) who complained of abnormal uterine bleeding (AUB) or abnormal ultrasound endometrial echoes. The patients were randomly divided into training and validation cohorts at a 7:3 ratio. The risk factors for EH/EEC were determined through the optimal subset regression analysis and a prediction model was developed. We used the concordance-index (C-index), and calibration plots in the training and validation sets to assess the prediction model. We drew the ROC curve in the validation set and calculated the area under the curve (AUC), as well as its accuracy, sensitivity, specificity, negative predictive value, and positive predictive value, and finally, converted the nomogram into a web page dynamic nomogram. Results: Predictors included in the nomogram model were body mass index (BMI), polycystic ovary syndrome (PCOS), anemia, infertility, menostaxis, AUB type, and endometrial thickness. The C-index of the model in the training and validation sets were 0.863 and 0.858. The nomogram model had good discriminatory power and was well-calibrated. According to the prediction model, the AUC of EH/EC, EH without atypia, and AH/EC were 0.889, 0.867, and 0.956, respectively. Conclusions: The nomogram of EH/EC is significantly associated with risk factors, namely BMI, PCOS, anemia, infertility, menostaxis, AUB type, and endometrial thickness. The nomogram model can be used to predict the EH/EC risk and rapidly screen risk factors in a women population with high risk.